Showing 1 - 10 of 564
Alzheimer Data on the effectiveness of these drugs from information beyond the short-term clinical trials (e.g. long-term clinical trials and non-trial data) are now emerging. In most cases, the results indicate that, at least for some patients, continued treatment with cholinesterase inhibitors...
Persistent link: https://www.econbiz.de/10005404597
Schizophrenia is a chronic disease that typically manifests during adolescence and early adulthood. Treatment of this disease consumes a significant proportion of the healthcare budget (billions of dollars in the US). Primary management options for schizophrenia include both pharmacologic and...
Persistent link: https://www.econbiz.de/10005404603
Patients with non-small cell lung cancer (NSCLC) have poor survival prospects, as most have advanced disease at diagnosis. Chemotherapy can be used to treat these patients if their performance status is good, although there are geographical differences in chemotherapy use. Combination...
Persistent link: https://www.econbiz.de/10005404605
The over-the-counter (OTC) conversion of loratadine was approved in the US in December 2002 for the treatment of allergic rhinitis, representing the first second-generation antihistamine (SGA) to be made available as an OTC product. This review examines the current evidence regarding the impact...
Persistent link: https://www.econbiz.de/10005404638
Primary open angle glaucoma is diagnosed principally on the basis of relevant visual field defects, typically supported by evidence of nerve fibre layer and optic nerve damage. An intraocular pressure above the normal range is an important risk factor but not a diagnostic requirement. Many cases...
Persistent link: https://www.econbiz.de/10005404673
Elevated cholesterol levels are associated with an increased risk of cardiovascular diseases. Treatment strategies promoting the associated health benefits from a reduction in elevated cholesterol levels have been outlined in guidelines published by the National Cholesterol Education Program....
Persistent link: https://www.econbiz.de/10005404725
Background: Missing data are potentially an extensive problem in cost-effectiveness analyses conducted alongside randomised clinical trials, where prospective collection of both resource use and health outcome information is required. There are several possible reasons for the presence of...
Persistent link: https://www.econbiz.de/10005404739
Persistent link: https://www.econbiz.de/10005404741
Bone densitometry is currently widely recommended for, and considered central to, identifying post-menopausal women and older men at high risk of fracture and establishing an indication for pharmacological fracture-prevention therapy. The purpose of this article is to comprehensively review...
Persistent link: https://www.econbiz.de/10005404744
We reviewed several cost-effectiveness analyses that modelled the costs and yield of newborn screening for sickle cell disease (SCD) in the US and the UK and discuss the ways in which newborn screening policies in each country evolved with regard to the results of the analyses. Each of the...
Persistent link: https://www.econbiz.de/10005404763